| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |